CEACAM8 Antikörper
Kurzübersicht für CEACAM8 Antikörper (ABIN2472305)
Target
Alle CEACAM8 Antikörper anzeigenReaktivität
Wirt
Klonalität
Konjugat
Applikation
Klon
-
-
Produktmerkmale
- Purified IgG
-
Aufreinigung
- Purified
-
Immunogen
- CML leucocytes
-
Isotyp
- IgG1
-
-
-
-
Applikationshinweise
- Optimal working dilution should be determined by the investigator.
-
Beschränkungen
- Nur für Forschungszwecke einsetzbar
-
-
-
Format
- Liquid
-
Konzentration
- 1.0 mg/mL
-
-
-
: "Induction of neutrophil degranulation by S100A9 via a MAPK-dependent mechanism." in: Journal of leukocyte biology, Vol. 87, Issue 5, pp. 905-14, (2010) (PubMed).
: "High neutrophil numbers in human carotid atherosclerotic plaques are associated with characteristics of rupture-prone lesions." in: Arteriosclerosis, thrombosis, and vascular biology, Vol. 30, Issue 9, pp. 1842-8, (2010) (PubMed).
-
-
- CEACAM8 (Carcinoembryonic Antigen-Related Cell Adhesion Molecule 8 (CEACAM8))
-
Andere Bezeichnung
- CD66b
-
Hintergrund
- Synonyms: BILIARY GLYCOPROTEIN
-
Gen-ID
- 1088
-
UniProt
- P31997
Target
-